• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲癣治疗及其管理的最新进展。

Recent advances in therapies for onychomycosis and its management.

作者信息

Gupta Aditya K, Stec Nadia

机构信息

Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, Canada.

Mediprobe Research Inc., London, Ontario, Canada.

出版信息

F1000Res. 2019 Jun 25;8. doi: 10.12688/f1000research.18646.1. eCollection 2019.

DOI:10.12688/f1000research.18646.1
PMID:31297182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6600855/
Abstract

Onychomycosis is the most common affliction of the nail. It may be caused by dermatophytes, yeasts, and non-dermatophyte molds. Traditionally, oral antifungal treatments have been used to treat the fungus, although they can be accompanied by side effects and drug interactions. Topical treatments provide an alternative modality, bypassing the systemic effects of oral drugs; recent research has centered on topical drug improvement and development. Physical and laser treatments are being used in conjunction with topicals, which may help penetrate the thick nail plate. In this review, techniques from all categories are outlined: both novel experimental approaches and progress and effectiveness of recently developed treatments. More long-term studies are required to determine the efficacy of various treatments, but cure rates are improved when patients adhere to treatments and follow preventative measures to avoid disease recurrence.

摘要

甲癣是最常见的指甲疾病。它可能由皮肤癣菌、酵母菌和非皮肤癣菌霉菌引起。传统上,口服抗真菌药物用于治疗这种真菌,尽管它们可能伴有副作用和药物相互作用。局部治疗提供了一种替代方式,避免了口服药物的全身作用;最近的研究集中在局部药物的改进和开发上。物理和激光治疗正与局部治疗联合使用,这可能有助于穿透厚厚的甲板。在这篇综述中,概述了所有类别的技术:包括新颖的实验方法以及最近开发的治疗方法的进展和有效性。需要更多的长期研究来确定各种治疗方法的疗效,但当患者坚持治疗并采取预防措施以避免疾病复发时,治愈率会提高。

相似文献

1
Recent advances in therapies for onychomycosis and its management.甲癣治疗及其管理的最新进展。
F1000Res. 2019 Jun 25;8. doi: 10.12688/f1000research.18646.1. eCollection 2019.
2
Emerging drugs for the treatment of onychomycosis.治疗甲真菌病的新兴药物。
Expert Opin Emerg Drugs. 2019 Dec;24(4):213-220. doi: 10.1080/14728214.2019.1685493. Epub 2019 Oct 31.
3
Efficacy of Lasers for the Management of Dermatophyte Toenail Onychomycosis.激光治疗甲真菌病的疗效。
J Am Podiatr Med Assoc. 2022 Mar 16;112(1):20-236. doi: 10.7547/20-236.
4
Management of toenail onychomycosis.趾甲甲真菌病的管理
Am J Health Syst Pharm. 1999 May 1;56(9):865-71. doi: 10.1093/ajhp/56.9.865.
5
New antifungal therapies for the treatment of onychomycosis.用于治疗甲癣的新型抗真菌疗法。
Expert Opin Investig Drugs. 2009 Jun;18(6):727-34. doi: 10.1517/13543780902810352.
6
How effective is efinaconazole in the management of onychomycosis?艾氟康唑治疗甲癣的效果如何?
Expert Opin Pharmacother. 2016;17(4):611-8. doi: 10.1517/14656566.2016.1146687. Epub 2016 Feb 15.
7
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.8%环吡酮甲涂剂溶液与美国用于治疗皮肤癣菌性足趾甲真菌病的新型口服抗真菌药物的药物经济学分析。
J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S81-95. doi: 10.1067/mjd.2000.109069.
8
Antifungal Drug Use for Onychomycosis.抗真菌药物治疗甲真菌病。
Am J Ther. 2019 May/Jun;26(3):e388-e396. doi: 10.1097/MJT.0000000000000696.
9
Emerging therapies for the treatment of ungual onychomycosis.治疗甲癣的新兴疗法。
Drug Dev Ind Pharm. 2015;41(10):1575-81. doi: 10.3109/03639045.2015.1033426. Epub 2015 May 22.
10
Drug delivery to the nail: therapeutic options and challenges for onychomycosis.药物递送至指甲:甲真菌病的治疗选择与挑战
Crit Rev Ther Drug Carrier Syst. 2014;31(6):459-94. doi: 10.1615/critrevtherdrugcarriersyst.2014008464.

引用本文的文献

1
Efficacy of Fractional Versus Fully Ablative CO Laser for Distolateral Onychomycosis: Experience With 20 Patients.分次与完全剥脱性CO激光治疗远端外侧甲真菌病的疗效:20例患者的经验
Dermatol Pract Concept. 2024 Jul 1;14(3):e2024121. doi: 10.5826/dpc.1403a121.
2
Severe drug eruption from oral terbinafine for mild onychomycosis-A case report from family practice and literature review: "Just an innocent little pill?".口服特比萘芬治疗轻度甲癣引发的严重药物疹——来自家庭医疗实践的病例报告及文献综述:“只是一片无害的小药丸?”
SAGE Open Med Case Rep. 2024 Mar 4;12:2050313X241235823. doi: 10.1177/2050313X241235823. eCollection 2024.
3
On the Basis of Sex: Impact and Treatment of Toenail Onychomycosis in Female Patients.基于性别:女性患者趾甲甲真菌病的影响与治疗
J Clin Aesthet Dermatol. 2023 Oct;16(10):52-57.
4
Linalool-Incorporated Synergistically Engineered Modified Liposomal Nanocarriers for Enhanced Transungual Delivery of Terbinafine against Onychomycosis.用于增强特比萘芬经甲递送以治疗甲真菌病的芳樟醇协同工程化修饰脂质体纳米载体
Materials (Basel). 2023 Jun 16;16(12):4424. doi: 10.3390/ma16124424.
5
Lasers' Q-switched treatment in skin and subcutaneous lesions - review.激光调Q治疗皮肤及皮下病变——综述
Postepy Dermatol Alergol. 2023 Apr;40(2):181-186. doi: 10.5114/ada.2023.127636. Epub 2023 May 31.
6
Membranolytic Activity Profile of Nonyl 3,4-Dihydroxybenzoate: A New Anti-Biofilm Compound for the Treatment of Dermatophytosis.壬基3,4-二羟基苯甲酸酯的膜溶解活性概况:一种用于治疗皮肤癣菌病的新型抗生物膜化合物。
Pharmaceutics. 2023 May 4;15(5):1402. doi: 10.3390/pharmaceutics15051402.
7
Investigation on Utility of Some Novel Terpenes on Transungual Delivery of Terbinafine for the Management of Onychomycosis.某些新型萜类化合物对特比萘芬经甲递送治疗甲真菌病效用的研究
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022202. doi: 10.5826/dpc.1204a202. eCollection 2022 Nov.
8
Fractional CO laser ablation leads to enhanced permeation of a fluorescent dye in healthy and mycotic nails-An imaging investigation of laser-tissue effects and their impact on ungual drug delivery.分数二氧化碳激光消融可增强荧光染料在健康指甲和灰指甲中的渗透——激光-组织效应及其对指甲药物递送影响的成像研究
Lasers Surg Med. 2022 Aug;54(6):861-874. doi: 10.1002/lsm.23541. Epub 2022 Apr 22.
9
Non-Dermatophyte Mold Dominated Onychomycosis in Patients Attending a Rank Higher Specialized Dermatology Clinic in Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴一家高级专业皮肤科诊所就诊患者中以非皮肤癣菌霉菌为主的甲真菌病
Clin Cosmet Investig Dermatol. 2022 Mar 23;15:507-518. doi: 10.2147/CCID.S357738. eCollection 2022.
10
Synthesis and Evaluation of the Antifungal and Toxicological Activity of Nitrofuran Derivatives.硝基呋喃衍生物的抗真菌活性及毒理学活性的合成与评价
Pharmaceutics. 2022 Mar 8;14(3):593. doi: 10.3390/pharmaceutics14030593.

本文引用的文献

1
Ciclopirox Hydroxypropyl Chitosan: Efficacy in Mild-to-Moderate Onychomycosis.环吡酮羟丙基壳聚糖:对轻至中度甲癣的疗效
Skin Appendage Disord. 2018 Nov;5(1):13-19. doi: 10.1159/000488606. Epub 2018 May 30.
2
Polyurethanes as New Excipients in Nail Therapeutics.聚氨酯作为指甲治疗中的新型辅料
Pharmaceutics. 2018 Dec 13;10(4):276. doi: 10.3390/pharmaceutics10040276.
3
A Practical Guide to Curing Onychomycosis: How to Maximize Cure at the Patient, Organism, Treatment, and Environmental Level.《甲真菌病治疗的实用指南:如何从患者、病原体、治疗和环境层面最大化治愈率》
Am J Clin Dermatol. 2019 Feb;20(1):123-133. doi: 10.1007/s40257-018-0403-4.
4
Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.新型口服三唑类抗真菌药物伏立康唑赖氨酸乙酯治疗甲真菌病的疗效和安全性:一项多中心、双盲、随机 III 期研究。
J Dermatol. 2018 Oct;45(10):1151-1159. doi: 10.1111/1346-8138.14607. Epub 2018 Aug 29.
5
Therapy of Skin, Hair and Nail Fungal Infections.皮肤、毛发和指甲真菌感染的治疗
J Fungi (Basel). 2018 Aug 20;4(3):99. doi: 10.3390/jof4030099.
6
Onychomycosis: Treatment and prevention of recurrence.甲真菌病:治疗和预防复发。
J Am Acad Dermatol. 2019 Apr;80(4):853-867. doi: 10.1016/j.jaad.2018.05.1260. Epub 2018 Jun 28.
7
Environmental and Genetic Factors on the Development of Onychomycosis.环境和遗传因素对甲癣发病的影响
J Fungi (Basel). 2015 Aug 31;1(2):211-216. doi: 10.3390/jof1020211.
8
Enhancement of tioconazole ungual delivery: Combining nanocapsule formulation and nail poration approaches.增强噻康唑的指甲传递:结合纳米胶囊制剂和指甲穿孔方法。
Int J Pharm. 2018 Jan 15;535(1-2):237-244. doi: 10.1016/j.ijpharm.2017.11.008. Epub 2017 Nov 7.
9
Precise laser poration to control drug delivery into and through human nail.精确激光穿孔控制药物递送入和穿过人指甲。
J Control Release. 2017 Dec 28;268:72-77. doi: 10.1016/j.jconrel.2017.10.014. Epub 2017 Oct 16.
10
Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomized phase 3 studies.5%他氟硼酸盐外用溶液治疗成人趾甲癣的疗效和安全性评估:两项随机3期研究8周研究后随访的汇总分析
J Dermatolog Treat. 2018 Feb;29(1):44-48. doi: 10.1080/09546634.2017.1329510. Epub 2017 May 30.